Log In
BCIQ
Print this Print this
 

TargetPrint

  Manage Alerts
Collapse Summary General Information
Company Agendia N.V.
DescriptionDiagnostic test to quantitatively determine the gene expression levels of the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor (EGF) receptor 2 (HER2; ErbB2; neu) in breast cancer tumor biopsies
Molecular Target Estrogen receptor 1 (ESR1) ; Progesterone receptor (PGR)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsQuantitative readout of ER, PR, HER2+ in breast cancer tumor biopsies
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today